Lawrence, MA, United States of America

Christopher R Areias

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignees: Raytheon Company, University of Massachusetts. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Christopher R. Areias

Introduction

Christopher R. Areias is a notable inventor based in Lawrence, Massachusetts. He has made significant contributions to the field of semiconductor applications through his innovative patents.

Latest Patents

Christopher holds a patent for a nanocomposite material designed for ultraviolet curable direct write semiconductor applications. His invention involves a chip-embedded printed circuit board featuring a cavity that accommodates a chip and utilizes a thixotropic dielectric filler. This filler effectively seals the chip within the printed circuit board, showcasing his expertise in creating advanced materials for electronic applications.

Career Highlights

Throughout his career, Christopher has worked with esteemed organizations, including Raytheon Company and the University of Massachusetts. His experiences in these institutions have likely enriched his knowledge and skillset, allowing him to innovate effectively within the semiconductor realm.

Collaborations

Christopher has had the opportunity to collaborate with accomplished individuals such as Craig A. Armiento and Yuri A. Piro. These partnerships may have played a crucial role in his inventive process and the advancement of his projects.

Conclusion

With a patented innovation that enhances semiconductor technology, Christopher R. Areias exemplifies the spirit of invention in the modern era. His work continues to influence the field and serves as an inspiration for aspiring inventors and engineers alike.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…